What is Humanin?
Mitochondrial-derived peptide studied for neuroprotection.
Humanin is a peptide encoded in mitochondrial DNA, studied for potential neuroprotective and longevity effects. Research is early-stage. Represents emerging mitochondrial peptide research.
What the evidence says
The overall evidence grade for Humanin is C (limited — early or preliminary data, mostly mechanistic or animal). Interesting research area but very limited human data.
Specific findings with supporting evidence:
- Mitochondrial-derived peptide. Evidence grade A.
- Shows neuroprotective effects in research. Evidence grade C.
Best-supported outcomes:
- Research interest only.
Where marketing outpaces evidence:
- The claim that "Proven longevity benefits" is not supported by the evidence (grade C).
- Marketing often overstates: Anti-aging miracle.
- Marketing often overstates: Neuroprotection proven.
Dose and timing
Take it in the morning. Research compound only.
Who it's for, and who should skip it
Most relevant for:
- Research interest only.
Not appropriate for:
- Those seeking proven therapy.
Safety and cautions
Important: Early research. Human clinical data very limited. Important: Not FDA approved. Experimental compound.
Common mistakes
- Expecting proven neuroprotection.
- Confusing research with proven therapy.
Myths vs reality
A common misconception: Humanin is a proven longevity peptide. In reality, research is in early stages.
How it interacts with other compounds
- Humanin works well alongside mots c — both mitochondrial-derived peptides.
Questions people ask
What makes humanin unique? One of the first discovered mitochondrial-encoded peptides.
Editorial note
This guide summarizes the published evidence on Humanin. It is educational content, not medical advice. Confirm with your clinician if you take prescription medications or manage a chronic condition.